TUBB3 role in the response of tumor cells to epothilones and taxanes
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2015, Vol 69, Issue 0
Abstract
Because of increased incidence of cancer and the development of resistance after treatment with typical drugs, new insights into the mechanisms of action of individual compounds are extremely valuable. In this article, we focus on taxanes, drugs belonging to the group of microtubule stabilizers, and their new generation - epothilones. Facing the fact that the molecular target for these compounds are microtubules, our attention was focused primarily on the role of overexpression of one of tubulin isotypes in response of tumor cells, particularly ovarian cancer to treatment with these compounds. On the basis of the literature data it can be concluded that one reason for the ineffectiveness of taxane is the resistance growing in the case of overexpression of b-tubulin class III- (TUBB3). Epothilones, however, due to their ability to bind equally to b-tubulin class I and III are effective in these cells, giving them an advantage over taxanes. It is necessary to emphasize the role of mikroRNA, transcription factors and other proteins associated with the activation of microtubules in development of resistance to taxanes and overcoming the resistance of the epothilones. Particularly interesting tubuseems to be the link between expression of TUBB3 and Glis proteins, which are end-effectors of Hedgehog pathway. Thanks to the confirmation that Gli1 overexpression is associated with decreased response to chemotherapy, it was possible to sensitize cells to epothilones after addition a suitable inhibitor.
Authors and Affiliations
Agnieszka Marczak, Aneta Rogalska
Pharmaceutical applications of graphene
Nowadays, dynamic development in nanotechnological sciences is observed. Nanoparticles are frequently used in medicine and pharmacy as delivery systems for different kinds of active substances. One of the latest develope...
Znaczenie białka macierzy jądrowej BLCA-4 w raku pęcherza moczowego
Rak pęcherza moczowego (RPM) występuje dosyć często i dotyka głównie osoby w starszym wieku. Zgodnie z informacją podaną przez Krajowy Rejestr Nowotworów w 2012 roku był to czwarty, pod względem zachorowania, nowotwór u...
W poszukiwaniu genu zespołu Gilles de la Tourette’a. Część 1. Różnorodność fenotypów klinicznych
Gilles de la Tourette, francuski neurolog i psychiatra, opisał w 1985 r. „chorobę tików”, którą później nazwano jego imieniem jako zespół Gillesa de la Tourette’a. Zespół Gillesa de la Tourette’a (GTS) jest chorobą neuro...
Intracellular glutathione level and efflux in human melanoma and cervical cancer cells differing in doxorubicin resistance
Introduction: Drug resistance continues to be a major problem in cancer treatment. Occurrence of this phenomenon is often associated with altered levels of glutathione (GSH) and GSH-related enzymes. The aim of the study...
Lung surgery for metastatic epithelial tumours
Introduction: The aim of this study is to evaluate outcomes following the surgical treatment of pulmonary metastases in patients with different types of epithelial cancers, as well as to identify prognostic factors after...